Accounting estimates based on an assumption of recovery from the impact of COVID-19 toward the fiscal year-end
First written in FY2021-Q1. 5 of 8 entries say "Restated". Latest entry: FY2022.
The whole theme swung hardest in 2026: 5 of 23 companies on the "Worse" side.
- FY2022ReframedAnnual report
「Although the timing of the end of the spread of COVID-19 variants remains uncertain, the Company expects the impact on business performance to be limited due to infection-prevention measures, including a third vaccine dose. In addition, although there are concerns about a global slowdown in economic activity resulting from the situation in Ukraine, the Company has made estimates based on the assumption that the impact on consolidated results for the fiscal year ending March 2023 will be immaterial.」
The assumptions underlying the accounting estimates have been updated to state that, although the timing of the end of the spread of variants remains uncertain, the impact will be limited due to a third vaccine dose and other measures, and the impact of the situation in Ukraine will be immaterial for the fiscal year ending March 2023. - FY2022-Q3RestatedAnnual report
「There have been no significant changes in the assumptions concerning the impact of COVID-19 or in the accounting estimates described in the annual securities report for the previous consolidated fiscal year.」
The disclosure continues to state that there have been no significant changes in the accounting assumptions or estimates concerning the impact of COVID-19. - FY2022-Q2RestatedAnnual report
「There have been no significant changes in the assumptions concerning the impact of COVID-19 or in the accounting estimates described in the annual securities report for the previous consolidated fiscal year.」
The disclosure continues to state that there have been no significant changes in the accounting assumptions or estimates concerning the impact of COVID-19. - FY2022-Q1RestatedAnnual report
「There have been no significant changes in the assumptions concerning the impact of COVID-19 or in the accounting estimates described in the annual securities report for the previous consolidated fiscal year.」
The disclosure continues to state that there have been no significant changes in the accounting assumptions or estimates concerning the impact of COVID-19. - FY2021ReframedAnnual report
「Although it is currently difficult to reasonably predict when the spread of COVID-19 will subside, the Company expects the challenging situation to continue due to new issues, including the spread of highly transmissible variants. Accordingly, the Company has made estimates based on the assumption that, despite a delay in economic recovery, the economy will gradually begin to recover from the third quarter as a result of the effects of vaccination and other factors.」
The accounting assumption concerning the impact of COVID-19 has been made more specific: recovery will gradually begin from the third quarter due to the effects of vaccination, while allowing for a delayed recovery caused by variants. - FY2021-Q3RestatedAnnual report
「There have been no significant changes in the assumptions concerning the impact of COVID-19 or in the accounting estimates described in the “Additional Information” section of the quarterly report for the first quarter.」
The disclosure continues to state that there have been no significant changes in the accounting assumptions or estimates concerning the impact of COVID-19. - FY2021-Q2RestatedAnnual report
「There have been no significant changes in the assumptions concerning the impact of COVID-19 or in the accounting estimates described in the “Additional Information” section of the quarterly report for the first quarter.」
The disclosure continues to state that there have been no significant changes in the accounting assumptions or estimates concerning the impact of COVID-19. - FY2021-Q1First statedAnnual report
「Based on the assumption that the impact of COVID-19 on the Group's businesses will recover toward the end of the current consolidated fiscal year, the Company makes accounting estimates, including the recoverability of deferred tax assets and the valuation of goodwill, using information available when preparing the quarterly consolidated financial statements.」
The Company makes accounting estimates, including the recoverability of deferred tax assets and the valuation of goodwill, based on the assumption that the impact of COVID-19 on its businesses will recover toward the end of the current consolidated fiscal year.